Aspira Women's Health Inc. (AWHL) income statement
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 2954.7%
- Operating margin
- -4059.4%
- Net margin
- -5885.3%
- Return on equity, FY2025
- 269.2%
Financial strength
- Current ratio
- 0.52
- Debt to equity
- -0.23
- Debt to assets
- 38.4%
- Cash to current liabilities
- 8.9%
Valuation
- P/E ratio
- –
- Price to sales
- 58.31
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?